IL1B and rheumatic disorder: The effect of rheumatism in the JWFSN-middle and JWFSN-high dose groups is particularly obvious, suggesting that the therapeutic effect of JWFSN on CIA rats may be through direct or indirect reduction of TNF-α, IFN-γ, and IL-1β expression and improve IL-4 and IL-10.